Daudi
Export
Burkitt's lymphoma; EBV positive
Cell Type:
Leukocyte (unspec.)
Tissue Origin:
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
L
A-020
1e6
51%
70%
Plasmid (general)
2 µg
100 µl
I/II/2b
Citations
Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes
Categories:
Transfection
Authors:
Garaud S, Le Dantec C, Berthou C, Lydyard PM, Youinou P, Renaudineau Y
In:
J Immunol (2008) 181(3): 2010-8
Gene expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors
Categories:
Transfection
Authors:
De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G, Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, Tosi P, Stein H, Giordano A, Leoncini L
In:
Blood (2007) 110(4): 1301-7
Talin1 Regulates TCR-Mediated LFA-1 Function
Categories:
Transfection
Authors:
Simonson WT, Franco SJ, Huttenlocher A
In:
J Immunol (2006) 177(11): 7707-14